Medications
US court rules to protect generic drug makers
Manufacturers of generic drugs cannot be sued for adverse side effects caused by products that they did not themselves design, the US Supreme Court ruled on Monday.
Jun 24, 2013
0
0
Page 11 - News tagged with drug manufacturer
Medications
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued ...
Apr 1, 2013
0
0
Diseases, Conditions, Syndromes
US meningitis death toll up to 23: CDC
The death toll in the United States from an unprecedented outbreak of fungal meningitis linked to a contaminated drug has climbed to 23 people, health officials said Saturday.
Oct 20, 2012
0
0
Medications
Some adverse drug events not reported by manufacturers to FDA by 15-day mark
About 10 percent of serious and unexpected adverse events are not reported by drug manufacturers to the U.S. Food and Drug Administration under the 15-day timeframe set out in federal regulations, according to an article ...
Jul 27, 2015
0
7
Medications
Mining information contained in clinical notes could yield early signs of harmful drug reactions
Mining the records of routine interactions between patients and their care providers can detect drug side effects a couple of years before an official alert from the U.S. Food and Drug Administration, a Stanford University ...
Apr 10, 2013
0
0
Diseases, Conditions, Syndromes
Problems at second US firm tied to meningitis outbreak
US federal health inspectors said Monday they have uncovered serious problems at a second Massachusetts pharmacy run by some of the same people whose tainted drugs caused a deadly meningitis outbreak.
Nov 12, 2012
0
0
Genetics
Asfotase alfa in hypophosphatasia in childhood/adolescence: Survival benefit for infants
Hypophosphatasia (HPP) is a rare congenital metabolic disorder. The frequency of severe courses of disease is estimated at 1:100 000: A deficiency of the enzyme phosphatase results in insufficient mineralization of the bones ...
Jan 27, 2020
0
4
Medications
Perampanel for epilepsy: Still no proof of added benefit
The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...
Aug 19, 2014
0
0
Oncology & Cancer
Vandetanib in thyroid cancer: No proof of added benefit
Vandetanib (trade name Caprelsa) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health ...
Nov 9, 2012
0
0
Medications
India probes charges of violations by drugs regulator
India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.
May 10, 2012
0
0
